Ivana Bozic, Ph.D. - Publications

Mathematics Harvard University, Cambridge, MA, United States 
Evolutionary Dynamics

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Gruber M, Bozic I, Leshchiner I, Livitz D, Stevenson K, Rassenti L, Rosebrock D, Taylor-Weiner A, Olive O, Goyetche R, Fernandes SM, Sun J, Stewart C, Wong A, Cibulskis C, et al. Growth dynamics in naturally progressing chronic lymphocytic leukaemia. Nature. PMID 31142838 DOI: 10.1038/s41586-019-1252-x  0.96
2017 Reiter JG, Makohon-Moore AP, Gerold JM, Bozic I, Chatterjee K, Iacobuzio-Donahue CA, Vogelstein B, Nowak MA. Reconstructing metastatic seeding patterns of human cancers. Nature Communications. 8: 14114. PMID 28139641 DOI: 10.1038/ncomms14114  0.96
2017 Makohon-Moore AP, Zhang M, Reiter JG, Bozic I, Allen B, Kundu D, Chatterjee K, Wong F, Jiao Y, Kohutek ZA, Hong J, Attiyeh M, Javier B, Wood LD, Hruban RH, et al. Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Nature Genetics. PMID 28092682 DOI: 10.1038/ng.3764  0.96
2016 Yamamoto Y, Offord CP, Kimura G, Kuribayashi S, Takeda H, Tsuchiya S, Shimojo H, Kanno H, Bozic I, Nowak MA, Bajzer Ž, Dingli D. Tumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy. British Journal of Cancer. 115: 195-202. PMID 27404586 DOI: 10.1038/bjc.2016.171  0.96
2016 Burger JA, Landau DA, Taylor-Weiner A, Bozic I, Zhang H, Sarosiek K, Wang L, Stewart C, Fan J, Hoellenriegel J, Sivina M, Dubuc AM, Fraser C, Han Y, Li S, et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nature Communications. 7: 11589. PMID 27199251 DOI: 10.1038/ncomms11589  0.96
2016 Bozic I, Gerold JM, Nowak MA. Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution. Plos Computational Biology. 12: e1004731. PMID 26828429 DOI: 10.1371/journal.pcbi.1004731  0.96
2015 Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, Kluth S, Bozic I, Lawrence M, Böttcher S, Carter SL, Cibulskis K, Mertens D, Sougnez CL, Rosenberg M, et al. Mutations driving CLL and their evolution in progression and relapse. Nature. 526: 525-30. PMID 26466571 DOI: 10.1038/nature15395  0.96
2015 Misale S, Bozic I, Tong J, Peraza-Penton A, Lallo A, Baldi F, Lin KH, Truini M, Trusolino L, Bertotti A, Di Nicolantonio F, Nowak MA, Zhang L, Wood KC, Bardelli A. Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers. Nature Communications. 6: 8305. PMID 26392303 DOI: 10.1038/ncomms9305  0.96
2015 Waclaw B, Bozic I, Pittman ME, Hruban RH, Vogelstein B, Nowak MA. A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity. Nature. 525: 261-4. PMID 26308893 DOI: 10.1038/nature14971  0.96
2015 Aad G, Abbott B, Abdallah J, Abdinov O, Aben R, Abolins M, AbouZeid OS, Abramowicz H, Abreu H, Abreu R, Abulaiti Y, Acharya BS, Adamczyk L, Adams DL, Adelman J, ... ... Bozic I, et al. Combined Measurement of the Higgs Boson Mass in pp Collisions at sqrt[s]=7 and 8 TeV with the ATLAS and CMS Experiments. Physical Review Letters. 114: 191803. PMID 26024162 DOI: 10.1103/PhysRevLett.114.191803  0.48
2015 Tomasetti C, Bozic I. The (not so) immortal strand hypothesis. Stem Cell Research. 14: 238-41. PMID 25700960 DOI: 10.1016/j.scr.2015.01.005  0.96
2014 Bozic I, Nowak MA. Timing and heterogeneity of mutations associated with drug resistance in metastatic cancers. Proceedings of the National Academy of Sciences of the United States of America. 111: 15964-8. PMID 25349424 DOI: 10.1073/pnas.1412075111  0.96
2013 Bozic I, Nowak MA. Cancer. Unwanted evolution. Science (New York, N.Y.). 342: 938-9. PMID 24264980 DOI: 10.1126/science.1247887  0.96
2013 Bozic I, Reiter JG, Allen B, Antal T, Chatterjee K, Shah P, Moon YS, Yaqubie A, Kelly N, Le DT, Lipson EJ, Chapman PB, Diaz LA, Vogelstein B, Nowak MA. Evolutionary dynamics of cancer in response to targeted combination therapy. Elife. 2: e00747. PMID 23805382 DOI: 10.7554/eLife.00747  0.96
2013 Reiter JG, Bozic I, Allen B, Chatterjee K, Nowak MA. The effect of one additional driver mutation on tumor progression. Evolutionary Applications. 6: 34-45. PMID 23396615 DOI: 10.1111/eva.12020  0.96
2013 Reiter JG, Bozic I, Chatterjee K, Nowak MA. TTP: Tool for tumor progression Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 8044: 101-106. DOI: 10.1007/978-3-642-39799-8_6  0.96
2012 Diaz LA, Williams RT, Wu J, Kinde I, Hecht JR, Berlin J, Allen B, Bozic I, Reiter JG, Nowak MA, Kinzler KW, Oliner KS, Vogelstein B. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature. 486: 537-40. PMID 22722843 DOI: 10.1038/nature11219  0.96
2012 Bozic I, Allen B, Nowak MA. Dynamics of targeted cancer therapy. Trends in Molecular Medicine. 18: 311-6. PMID 22595628 DOI: 10.1016/j.molmed.2012.04.006  0.96
2010 Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA. Distant metastasis occurs late during the genetic evolution of pancreatic cancer Nature. 467: 1114-1117. PMID 20981102 DOI: 10.1038/nature09515  0.96
2010 Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA. Accumulation of driver and passenger mutations during tumor progression Proceedings of the National Academy of Sciences of the United States of America. 107: 18545-18550. PMID 20876136 DOI: 10.1073/pnas.1010978107  0.96
Show low-probability matches.